Review The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors
Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are widely used to treat HIV-1-infected individuals; indeed most first-line antiretroviral therapies typically include one NNRTI in combination with two nucleoside analogs. In 2008, the next-generation NNRTI etravirine was approved for the trea...
Збережено в:
| Автор: | |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2014-07-01
|
| Серія: | Viruses |
| Предмети: | |
| Онлайн доступ: | http://www.mdpi.com/1999-4915/6/8/2960 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|